EnLiSense CCM Advances Validation of Real-Time IBD Inflammatory Biomarker Monitoring with Two Recent Peer-Reviewed Longitudinal Studies

DALLAS, February 15, 2024--EnLiSense CCM, a pioneer in non-invasive sweat-sensor technology for real-time health monitoring, is thrilled to announce a groundbreaking advancement in the world of Inflammatory Bowel Disease (IBD) management. Our innovative IBD Aware device offers the first solution for continuous, non-invasive monitoring of IBD through the power of sweat-sensing technology.

Related Keywords

United States ,Dallas ,Texas ,Americans ,Andres Hurtado Lorenzo ,Shalini Prasad ,Robertp Hirten ,Translational Research ,Crohn Colitis Foundation ,Crohn Colitis Foundation Novel Technologies Initiative Award ,Department Head ,University Of Texas At Dallas ,National Institute Of Health Award ,Icahn School Of Medicine At Mount Sinai ,Inflammatory Bowel Disease ,Icahn School ,Mount Sinai ,Colitis Foundation ,Assessment Of Sweat ,Alpha In Inflammatory Bowel Disease Using ,Wearable Device ,Nature Scientific Reports ,Inflammatory Bowel Disease Using ,Senior Vice President ,Novel Technologies ,Clinical Director ,Hasso Plattner Institute ,Digital Health ,Novel Technologies Initiative Award ,National Institute ,Rohns Colitis Foundation ,Sensor Technology ,Chronic Disease Management ,Chronic Inflammation ,Technology ,